Orient Pharma Co., Ltd. (TPEX:4166)

Orient Pharma Revenue

Orient Pharma had revenue of 331.22M TWD in the quarter ending March 31, 2026, with 4.52% growth. This brings the company's revenue in the last twelve months to 1.41B, up 11.94% year-over-year. In the year 2025, Orient Pharma had annual revenue of 1.40B with 14.52% growth.

• Revenue (ttm): 1.41B
• Revenue Growth: +11.94%
• P/S Ratio: 3.85
• Revenue / Employee: 8.18M
• Employees: 173
• Market Cap: 5.44B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.40B	177.56M	14.52%
Dec 31, 2024	1.22B	332.90M	37.41%
Dec 31, 2023	889.91M	378.05M	73.86%
Dec 31, 2022	511.86M	48.52M	10.47%
Dec 31, 2021	463.34M	51.33M	12.46%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 28, 2026

Data Sources Report a data error